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Summary The reflex sympathetic dystrophy syndrome (RSDS) consists of a triad of pain, edema and sympathetic dysfunction 
of an extremity following trauma, peripheral nerve injury or central nervous system disorder. Reflex sympathetic dystrophy syndrome 
is a difficult and costly pain syndrome to treat. One of the difficulties in evaluating treatment efficacy is the objectification and 
quantification of patient findings. The purpose of this investigation was to develop a simple, reproducible and systematic evaluation 
of pain and neurologic impairment in RSDS. The protocol evaluation included the following measures of pain and impairment: (1) 
objectification of distal joint pain by palpation (O-4 scale); (2) volumetric measurement by w-ater displacement of the distal limb; (3) 
skin temperature measurement; (4) active range of motion assessment of the affected limb (AROM); (5) McGill Pam Questionnaire 
(MPQ); and (6) visual analogue pain scale (VAS). 
Seventeen subjects with definite or probable RSDS were evaluated. The mean age of patients was 35.6 years + 8.0 years (F 2 
S.E.M.), and the mean duration of symptoms was 11.8 + 4.8 months. There were an equal number of subjects with upper and lower 
extremity involvement. The VAS had significant correlations with limb volume, AROM-lower extremity and joint pain indices 
(P -C 0.0005). The MPQ subscales had robust correlation with the joint pain indices alone (P < 0.0001). Skin temperature was not 
predictive of changes in joint pain score, AROM, limb volume or subjective pain measures. However, there was internal consistency 
between volumetric and AROM measures and joint pain indices. This protocol is recommended for use in therapeutic trials for the 
treatment of the RSDS. 
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Introduction 
The reflex sympathetic dystrophy syndrome 
(RSDS) consists of a triad of pain, edema and 
vasomotor instability of an extremity following 
peripheral limb trauma or central nervous system 
disorder [12-141. In this study, we were interested 
in patients who met Kozin’s criteria for definite or 
probable RSDS [12-141. This included distal limb 
pain, and either diffuse swelling or vasomotor 
instability of the extremity. The RSDS is an ex- 
tremely difficult and costly syndrome to treat. 
Correspondence to: Gary Davidoff, M.D., Department of 
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One of the difficulties in previous reports of treat- 
ment efficacy is the lack of uniform quantification 
of treatment outcome, as defined by change in 
pain measurement or improvement in function. 
The non-uniformity of outcome measurement, as 
well as the lack of consistent diagnostic criteria 
in previous studies [1,2,4,5,7,11-14,17,18,20,22], 
makes it difficult to draw inferences from previous 
therapeutic trials in RSDS patients. We have de- 
veloped a simple, quick and reproducible method 
for systematic evaluation of pain and imp~rment 
in the RSDS. The purpose of this study was to 
investigate the utility of this protocol and how 
various objective and subjective measurements of 
pain and function varied with the course of treat- 
ment in this patient group. 
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Methods 
Subjects 
Seventeen patient-subjects were chosen for par- 
ticipation and measurement in this study. Inclu- 
sion criteria consisted of the following: (A) age 
over 11 years; (B) duration of pain syndrome > 1 
month; (C) no evidence of involvement of a con- 
tralateral extremity, as defined by a negative clini- 
cal exam and a negative 3-phase bone scan; (D) 
no previous history of sympathectomy of the af- 
fected extremity. All patients met Kozin’s criteria 
for definite or probable RSDS [12-141. This in- 
cluded distal limb pain and either diffuse limb 
edema or vasomotor instability of the extremity 
(e.g., abnormal skin temperature, trophic skin 
changes, hyperhydrosis). 
Procedure 
Each patient underwent a comprehensive inter- 
view in which the history of the RSDS was re- 
viewed in detail. Pertinent data were obtained 
including age, sex, duration of pain, presumed 
etiology, previous diagnostic and therapeutic in- 
terventions and associated medical conditions. A 
thorough neurologic and general physical ex- 
amination was performed on each patient. A 3- 
phase bone scan with Tc-99m(Sn) methylene- 
diphosphonate (Tc-99m MDP) was performed. 
At the initial consultation the following evalua- 
tion was performed by research physical or oc- 
cupational therapists. Members of the staff of the 
physical therapy division evaluated patients with 
lower extremity RSDS and the upper extremity 
patients were evaluated by members of the oc- 
cupational therapy division. Two of the authors 
(KM., M.A.) assured consistent evaluation be- 
tween a small cadre of treating therapists. The 
evaluation protocol consisted of the following: 
i I i Measurement of joint pain of the hand or foot 
by palpution using a I-point scale us follows: 0 = no 
pain; 1 = mild pain to deep palpation; 2 = severe 
pain to deep palpation; 3 = severe pain to mild 
palpation; 4 = hyperesthesia. 
Joint pain was evaluated in the hand and wrist 
for all interphalangeal, metacarpalphalangeal and 
wrist joints. Evaluation of the foot and ankle 
consisted of palpation of the interphaiangeal and 
metatarsalphalangeal joints of the foot and the 
tibio-talar joint. A total joint pain score was de- 
rived by summation of the individual pain scores 
for each joint. 
(21 Limb i~olu~e. Evaluation of asymmetric in- 
crease in limb volume was performed by volumet- 
ric measurement of the extremities. For measure- 
ment of the upper extremity, the hand was im- 
mersed to a point just proximal to the lateral 
styloid process of the wrist in a 2 liter laboratory 
beaker. Measurement of the foot was performed 
by immersing the foot into a 5 gallon glass vessel 
(fish tank). The foot was immersed to a point 6 cm 
proximal to the distal edge of the lateral malleo- 
lus. In both cases the volume measurement was 
determined based on the average of 3 trials. The 
contralateral unaffected extremity was also mea- 
sured to serve as a control for each patient. The 
percent limb volume (LIMB VOL) increase was 
defined as: 
(volume llrnb affected - volumelimb unaffected ) X 100 --_ 
vo1ume limb unaffected 
A limb volume difference > 5%> was considered 
abnormal. 
1.3) Skirt temperature measurement qf hunds or 
feet (in “Cj. Skin temperature of the hand was 
measured over the palmar surface in the web 
space between the first and second metacarpal 
joints and fourth and fifth metacarpal joints. 
Lower extremity temperatures were taken on the 
dorsum of the foot between the first and second 
metatarsal joints and between the fourth and fifth 
metatarsal joints. These temperatures were aver- 
aged and subtracted from the mean temperature 
obtained in similar fashion from the unaffected 
~ontralateral extremity. A temperature difference 
of f 0.5” C was considered abnormal. 
C4) Active range of motion ~A~~M~ of he a)- 
fected distal extremity. In the upper extremity this 
was generated by the average distance from the 
digital pads (II-V) to the distal palmar crease. For 
the lower extremity this consisted of goniometric 
measurement of ankle dorsiflexion, plantar flex- 
ion. eversion and inversion. The degree of impair- 
ment of active range of motion of the lower ex- 
tremity CAROM-LE) was given by the difference 
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between the expected degrees of normal ankle 
range minus the actual measurement of the active 
range of motion of the ankle in the planes of 
eversion, inversion, plantar and dorsiflexion. 
Prior to the actual physical assessment, the 
following subjective pain inventories were admin- 
istered to each patient: 
(A) The McGill Pain Questionnaire (MPQ). The 
MPQ [15] generates information concerning affec- 
tive, sensory and evaluative aspects of pain. Two 
types of measurement were obtained from the 
MPQ: the pain rating index (PRI) was based upon 
the rank values of words selected from a 28item 
inventory to describe the sensory (PRI-S), affec- 
tive (PRI-A), evaluative (PRI-E), and total (PRI-T) 
aspects of pain. In addition the number of words 
chosen (NWC) from the same 20 category word 
list was recorded. The MPQ has been reported by 
many authors to be a valid and reliable instrument 
for pain assessment [8,9,16,19,211. In this study 
the patient was allowed to fill out the MPQ while 
an investigator was available to answer questions 
concerning directions for administration. No in- 
formation was given by the investigator with re- 
gard to definition of various pain items. 
(B) The Visual Analog Scale (IO]. This was a 
100 mm line printed on a simple 8.5” x 11” sheet 
of paper. One extreme of the line indicates no 
pain, the other extreme indicates severe pain. The 
patient was asked to place an x where he/she 
would rank his/her present pain intensity. The 
VAS has been demonstrated to be a reliable and 
reproducible evaluation of pain intensity for 
chronic pain patients [lo]. 
This entire protocol was repeated at bi-weekly 
intervals for an 8 week period of treatment for 
each patient. 
Data analysis 
Comparisons of parametric variables including 
pain duration and pain measurement between up- 
per and lower extremity patient groups were per- 
formed using a Student’s t test. All confidence 
intervals are given as f2 standard errors of the 
mean (2 S.E.M.). Simple and multiple linear re- 
gression analyses were used to evaluate the rela- 
tionship between objective and subjective pain 
measures observed during various intervals over 
the course of treatment. All data analyses were 
performed utilizing the Michigan Interactive Data 
Analysis System [6]. 
Results 
Seventeen subjects with definite or probable 
RSDS [12-141 were evaluated. The mean age was 
35.6 _t 8.0 years (_t 2 S.E.M.). Five patients (29.4%) 
were male. Nine patients (52.9%) had upper ex- 
tremity involvement, with the remaining patients 
having solely lower extremity involvement. Preced- 
ing trauma could be implicated as an etiologic 
factor in 14 patients (X2.4%), with a latency of 
weeks to months between the predisposing factor 
and the development of symptoms consistent with 
RSDS. Two patients had a history of severe central 
nervous system damage (stroke, meningitis) and 1 
patient had no att~butable factor preceding the 
development of symptoms. The mean duration of 
time between the onset of symptoms and evalua- 
tion in clinic was 11.8 + 4.8 months. 
Fifteen patients underwent electrodiagnostic 
studies (EDX) performed by a physiatrist or neu- 
rologist in the Electrodiagnostic Laboratory of 
The University of Michigan Hospitals. Twelve 
EDX studies were normal. The remaining 3 
abnormal studies consisted of mononeuropathy [2j 
and polyradiculopathy [l]. All patients underwent 
a 3-phase bone scan. Nine patients had abnor- 
mally increased uptake in the delayed images con- 
sistent with RSDS [12-141. The remaining pa- 
tients had normal blood flow, blood pool and 
uptake. All patients had evidence of articular 
tenderness in the hand and wrist, or foot and 
ankle. In the hand, the metacarpal joint was most 
commonly affected. In the foot, the most com- 
monly involved joints were the metatarsals. Nine 
patients had abnormally increased limb volume. 
Twelve patients had abnormally decreased skin 
temperature ( > 0.5 o C difference between extremi- 
ties). Eleven patients had evidence of trophic skin 
changes and 4 patients had evidence of abnormal 
sweating. 
All patients were treated with a therapeutic 
exercise program for an 8 week period (biw or 
tiw). Most patients also received oral corti- 
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costeroids or regional sympathetic blockade as 
adjunctive therapy. The purpose of this study was 
to develop a useful clinical instrument for mea- 
surement of outcome in the RSDS. Consequently, 
data are not reported stratified by treatment 
method. 
The baseline pain rating index (PRI) from the 
McGill Pain Questionnaire (MPQ) was 23.1 + 6.5. 
The number of words chosen (NWC) from the 
MPQ at baseline was 9.6 _t 1.9. The baseline visual 
analog scale (VAS) rating was 55.1 _t 13.0. 
Squared correlation coefficients from linear re- 
gression analyses of pain and function measures 
before and during treatment are given in Table I. 
The VAS had significant correlations with limb 
volume, active range of motion and joint pain 
(Fig. 1). The PRI-T and NWC correlated only 
with active range of motion of lower extremities 
and joint pain indices. There was also a very 
strong correlation with active range of motion of 
upper or lower extremities and limb volume. There 
was no correlation whatsoever between changes in 
skin temperature and either objective or subjective 
TABLE I 
SQUARED CORRELATION COEFFICIENTS FOR LIN- 
EAR REGRESSION OF PAIN AND FUNCTION MEA- 
SURES IN REFLEX SYMPATHETIC DYSTROPHY SYN- 
DROME 
AROM = active range of motion; NWC = number of words 
chosen-MPQ: PRI = pain rating intensity-MPQ; VAS = visual 
analog pain scale; PRI-T = pain ranking index, total. 
Limb Skin AROM- AROM- Joint 
VOl. temp. UE LE pain 
Limb vol. - 
Skin temp. 0.049 -- 
AROM-UE 0.180 d 0.111 ~ 
AROM-LE 0.454 ’ 0.022 - 
Joint pain 0.246 ’ 0.030 0.068 0.636 ” - 
NWC 0.011 0.009 0.026 0.159 il 0.278 f 
VAS 0.160 e 0.000 0.167 a 0.508 f 0.341 f 
PRI-‘I 0.023 0.011 0.053 0.263 ’ 0.324 f 
d P < 0.05. 
h I’ < 0.01. 
c I’ < 0.005. 
d P < 0.001. 
* P < 0.0005. 
r P<O.OOOl. 
120.0 c N = 28 OUT OF 28 . ” 106.7 
10.7 32.3 53.8 75.4 970 
VAS 
Ftg. 1. Active range of motion (AROM) versus visual analog 
scale (VAS), lower extremities only. 
measures of pain and function in this patient 
group. 
The squared correlation coefficients for linear 
regression analyses of pain scales and subscales 
before and during treatment are reported in Table 
II. There was a robust correlation between the 
PRI subscales, PRI-T and NWC of the MPQ (Fig. 
TABLE II 
SQUARED CORRELATION COEFFICIENTS FOR LIN- 
EAR REGRESSION OF PAIN SCALES AND SUBSCALES 
IN REFLEX SYMPATHETIC DYSTROPHY SYNDROME 
NWC = number of words chosen; VAS = visual analog scale; 
PRI-T = pain ranking index, total; PRI-A = pain ranking in- 
dex, affective; PRI-E = pain ranking index, evaluative; PRI-S 
= pain ranking index. sensory. 
NWC VAS PRI-T PRI-A PRI-E PRI-S 
NWC ~ 
VAS 0.368 ’ ~ 
PRI-T 0.822 ’ 0.445 ’ - 
PRI-A 0.29 r 0.05 0.35 ’ ~~ 
PRI-E 0.42 ’ 0.25 ’ 0.53 0.33 - 
PRI-S 0.73 f 0.51 f 0.83 0.34 i 0.43 ’ - 
,’ P < 0.05. 
” P co.01. 
L P < 0.005. 
l’ P<O.ool. 
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E 24.4 - 
a 
18.3 - 
12.2 - r*=0.82 Ft1,53)=246.( 
6.1 - 
PRI = - 1.19k2.47 (NWC) 
OO: 19.0 
NWC 
Fig. 2. Pain ranking index (PRI) versus number of words 
chosen (NWC). 
2). There was a somewhat less robust correlation 
between PRI-T, affective pain rate index (PRI-A), 
sensory pain rating index (PRI-S) and the VAS. 
There was no correlation between the PRI-A sub- 
scale and the VAS. 
The following case illustrates how this method 
can be used to chart patient progress during treat- 
ment. F.R. was a &year-old ant-h~ded white 
male who presented to the Emergency Room of 
the University of Michigan Hospital in April, 
1986. There was a history of mild discomfort in 
the right hand and wrist since October, 1985. At 
that time he had suffered trivial injuries in foot- 
ball practice to the right shoulder without fracture 
or dislocation. The patient described swelling and 
discoloration of the extremity off and on over 
subsequent months. Approximately 3 weeks prior 
to presentation, he developed severe swelling and 
pain in the right hand and increased numbness 
distal to the mid-forearm in a glove-like distribu- 
tion. Electrodiagnostic studies were negative. He 
also underwent non-invasive flow studies and 
venography which were negative for venous 
t~ombotic disease of the right upper extremity. 
The patient was then given the diagnosis of defi- 
nite reflex sympathetic dystrophy of the right up- 
per extremity. At the initial presentation, the right 
hand was increased 22% beyond the volume of the 
left hand. There was no skin temperature dif- 
ference. Active range of motion was profoundly 
impaired, with an average measurement of 4.9 cm. 
The objective joint pain score was 16. The Melzack 
Pain Questionn~re demonstrated 7 words chosen 
with a pain rating index (PRI) of 12. The visual 
analog scale score was 48. The patient was not 
taking any medications at the time of presen- 
tation. Following initial clinical assessment, the 
patient was placed on a 2 week course of oral 
prednisone, 1 mg/kg. This was followed by a 2 
week taper of oral corticosteroid. In addition, the 
patient began an aggressive physical and occupa- 
tional therapy program twice a week. Fig. 3 il- 
Limb Volume 
Number of Words Chosen 
X Umb Volume 
Humbsr of ‘#or& Choeen 
Skin Temperature Difference Pain Ranking Index 
skin Temp4mtun rlmmnos PaIn RonkIng Index 
Active Range of Motion (MOM) w 8uaI Analog Pain Scale Rating (MS) 
*ROM In cm “Is 
Joint Pain Index 
Joint Poh index 
Fig. 3. Pain and function measures during and after treatment 
of patient F.R. for reflex sympathetic dystrophy. 
lustrates the patient’s progress, monitored by serial 
2 week evaluations. By week 8 the patient had 
nearly no edema of the right hand and no evi- 
dence of objective or subjective pain in the right 
hand. At assessment 19 weeks after the beginning 
of treatment, the patient had developed some 
edema of the right hand with a 1.25 o C skin 
temperature difference, with the right hand cooler 
than the left. The patient continued to deny any 
objective or subjective evidence of pain. However, 
it was felt on this basis that the patient continued 
to have abnormal sympathetic flow to the right 
upper extremity and was cautioned against par- 
ticipating in contact sports or other activities which 
might be likely to traumatize his right arm and 
reproduce the syndrome. 
Discussion 
Reproducible and reliable outcome measure- 
ments are critical to efficacy studies of treatment 
outcome in the RSDS. Wang et al. [22] conducted 
an open trial of central sympathetic blockade for 
the treatment of the RSDS. The comparison group 
consisted of a historical patient cohort which had 
received only physical therapy. Their outcome 
measure was a 5-point rating of subjective pain 
relief. Measurement of limb edema, joint pain, 
vasomotor instability or function was never docu- 
mented either before or after treatment. These 
measures would have done much to support the 
validity of their findings. Similar difficulties in 
design of outcome measurement can be found in 
other studies [4,11,17,20]. 
Bonelli et al. [I] quantified vasomotor changes, 
range of motion (not specified if this was active or 
passive), visual analog pain scale and presence of 
hyperpathia in their trial comparing the efficacy 
of regional versus central sympathetic blockade 
for the treatment of the RSDS. However, these 
outcomes were reported as either ‘improvement’ 
or ‘no change.’ No statistical analysis was per- 
formed to analyze the group changes on these 
variables after treatment. Poplawski et al. [18] 
truncated similar detailed findings of objective 
and subjective pain and function in their trial of 
regional sympathetic block into a 5-point scale 
reflecting overall change in pain, function and 
edema. No description was given as to how this 
scale was generated or what cut-off points were 
used for the collapsed rating of pain and function 
measures. A similar problem in design methodol- 
ogy can be demonstrated in the study by Driessen 
et al. [S]. 
Repeated measures of pain and function were 
reported in the trials by Glynn et al. [7] and Kozin 
ct al. [12-141. Glynn et al. [7] described repeated 
measures taken at 3 points: pre-sympathetic 
blockade, immediately after block and 7 days 
post-sympathetic blockade. Follow-up time was 
inadequate to allow observation of improvement 
for a clinically relevant and functional period (e.g., 
3 -6 months). Kozin et al. [12-141 performed sys- 
tematic repeated measures of ring size (indirect 
measure of edema), joint tenderness (via dolorime- 
try) and grip strength in their clinical trials of oral 
corticosteroids and stellate ganglionic blockade. 
Ring size measurement has not seen great clinical 
application, because of the multiple measurement 
required (all interphalangeal joints on both hands). 
In addition, ring size measurement is more dif- 
ficult to reproduce in the foot, due to the smaller 
circumference of the digits. Grip strength is a poor 
measure of functional outcome in a patient sample 
with traumatic peripheral mononeuropathies and 
central nervous system disorders, common pre- 
cipitants of the RSDS [4,20]. 
The purpose of this investigation was to de- 
velop a protocol of objective and subjective mea- 
sures of pain and function to evaluate outcome in 
the reflex sympathetic dystrophy syndrome 
(RSDS). The objective measurements of limb 
volume, skin temperature, and active range of 
motion were reproducible within +50/c on repli- 
cate observations on the same patient on the same 
day. The time required to perform the evaluation 
was approximately 45 min. The criteria for inclu- 
sion in this study were strictly enforced. Only 
patients with definite or probable RSDS were 
included to ensure a homogenous patient &ample. 
Patients were excluded if they had bilateral RSDS, 
as the contralateral extremity was used as a con- 
trol for evaluating differences in skin temperature 
and limb volume. Consequently, this protocol 
would not be applicable for patients with bilateral 
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findings consistent with RSDS. Patients with 
surgical sympathectomy or chemical sympathec- 
tomy were excluded, since these patients would 
have had abnormal skin temperature which would 
be unlikely to change with successful treatment. 
Several interesting findings can be interpreted 
from Table I, describing the relationship between 
objective and subjective measures of pain and 
function during treatment for the RSDS. There 
was no correlation between skin temperature and 
any of the objective or subjective parameters of 
pain and function. Since most patients demon- 
strated a clear improvement in their pain syn- 
drome during the treatment program, the continu- 
ing abnormality in skin surface temperature was 
suggestive of a quiescent, subclinical picture of 
ongoing abnormal sympathetic activity. This may 
explain why many patients continue to complain 
of recurring problems with chronic pain in RSDS. 
There was a strong positive correlation between 
active range of motion of the lower extremities 
and joint pain, but no such correlation was found 
for active range of motion of the upper extremities 
(Table I). Nearly all patients achieved normal 
active range of motion of the hand at the comple- 
tion of treatment. This was apparently accom- 
plished in spite of the continuing pain of which 
patients complained. The number of words chosen 
(NWC) and the total pain rating index (PRI-T) 
correlated only with active range of motion of 
lower extremities and joint pain indices (Table I). 
Multiple linear regression analyses indicated that 
the majority of variance for these 2 subjective pain 
indices (NWC, PRI-T) could be explained solely 
on the basis of change in the joint pain index 
(Table I). However, the visual analog scale (VAS) 
demonstrated robust and statistically significant 
positive correlations with all objective measures of 
pain and function, with the exception of skin 
temperature (Table I). Although the VAS is gener- 
ally considered limited by its unidimensional char- 
acter in pain studies, it would appear to be a 
potentially valuable instrument, superior to the 
MPQ for brief clinical assessment of patient pro- 
gress during treatment for the RSDS. 
Use of the MPQ provided quantification of 
sensory, affective and evaluative components of 
pain in this patient group during treatment. Val- 
ues of the MPQ subscales generated by this sam- 
ple equaled or exceeded those reported by patients 
with other pain syndromes, including menses, 
arthritis, cancer, phantom pain, toothache and 
spinal cord dysesthetic pain [3,8,9,15,16,21]. Inter- 
correlation of the 3 MPQ subscales (Table II) 
suggests that most of the variance in the total pain 
rating index (PRI-T) was the result of the number 
of words chosen (NWC) and the sensory pain 
rating index (PRI-S). There was a robust correla- 
tion between PRI-T, PRI-S, evaluative pain rating 
index (PRI-E) and the visual analog scale (VAS) 
(Table II). There was no correlation between PRI- 
A and the VAS, which is consistent with the 
unidimensional characteristics of pain description 
generated by the VAS [lo]. 
This investigation describes a simple, repro- 
ducible and internally consistent protocol for sys- 
tematic measurement of pain function in the 
RSDS. A uniform system of outcome measure- 
ment will aid in allowing comparison of various 
clinical trials for the treatment of this painful and 
disabling condition. 
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